These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21505608)

  • 1. The diagnosis and treatment of hypertrophic cardiomyopathy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Dtsch Arztebl Int; 2011 Apr; 108(13):209-15. PubMed ID: 21505608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.
    Faber L
    Adv Med; 2014; 2014():464851. PubMed ID: 26556411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
    Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Syncope in hypertrophic (obstructive) cardiomyopathy].
    Seggewiß H; Koljaja-Batzner A; Seggewiß K; Meesmann M
    Herzschrittmacherther Elektrophysiol; 2018 Jun; 29(2):178-182. PubMed ID: 29761339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy].
    Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E
    Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience.
    Tunca Sahin G; Ozgur S; Kafali HC; Sevinc Sengul F; Haydin S; Guzeltas A; Ergul Y
    Pediatr Int; 2021 Jan; 63(1):37-45. PubMed ID: 32682351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of hypertrophic cardiomyopathy - the most common inherited heart disease].
    Magnusson P; Gadler F; Mörner S
    Lakartidningen; 2018 Jun; 115():. PubMed ID: 29893985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
    Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
    Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L; Cannon RO; Tripodi D; Panza JA
    Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment.
    Musat D; Sherrid MV
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():9-17. PubMed ID: 17162264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Hypertrophic Cardiomyopathy: Diagnosis and Management.
    Litt MJ; Ali A; Reza N
    Vasc Health Risk Manag; 2023; 19():211-221. PubMed ID: 37050929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: a systematic review.
    Maron BJ
    JAMA; 2002 Mar; 287(10):1308-20. PubMed ID: 11886323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death].
    Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA
    Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy: Clinical Update.
    Geske JB; Ommen SR; Gersh BJ
    JACC Heart Fail; 2018 May; 6(5):364-375. PubMed ID: 29655825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).
    Mirabel M; Damy T; Donal E; Huttin O; Labombarda F; Eicher JC; Cervino C; Laurito M; Offredo L; Tafflet M; Jouven X; Giura G; Desnos M; Jeunemaître X; Empana JP; Charron P; Habib G; Réant P; Hagège A;
    Int J Cardiol; 2019 Jan; 275():107-113. PubMed ID: 30316646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.